Can psychedelics be the quick fix for depression? It’s certainly looking that way, according to the first major study that’s putting DMT (N-dimethyltryptamine) — the active, hallucinogenic ingredient found in ayahuasca — at the forefront of early trials.

The clinical trial by UK-based biotech company Small Pharma explored the benefits of using DMT to treat major depressive disorder, through a short IV infusion of DMT in 34 patients. In addition to supportive psychotherapy, participants — all........

© Mic